Narayana Kamath

Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.

Ram Ganapathi, Andreas I. Constantinou, Narayana Kamath et al. · Molecular Pharmacology · 1996 · 35 citations

Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone

Narayana Kamath, Dale Grabowski, Jeanne Ford et al. · Biochemical Pharmacology · 1992 · 25 citations

Hematological Malignancy, Oncogenic Agent, Topoisomerase Ii +8

Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: Relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells

Ram Ganapathi, Narayana Kamath, Andreas I. Constantinou et al. · Biochemical Pharmacology · 1991 · 21 citations

Dna Damage, Oncogenic Agent, Topoisomerase Ii +9

1,10-Phenanthroline Potentiates Cytotoxicity of Hydroxyurea in Human Chronic Myeloid Leukemia Cells

Narayana Kamath, Kapaettu Satyamoorthy, M.P. Chitnis et al. · Oncology · 1989 · 15 citations

Hematological Malignancy, Molecular Pharmacology, Medicinal Chemistry +15

Potentiation of tamoxifen activity by verapamil in a human breast cancer cell line

V. D. Gupta, Narayana Kamath, George T. Tkalcevic et al. · Biochemical Pharmacology · 1994 · 10 citations

Breast Oncology, Medicine, Tamoxifen Activity +8